VKTX · Viking Therapeutics, Inc. · Analyst Estimates
Market Cap
$3.81B
Shares
116.65M
Analyst Estimates
Compare analyst forecasts for Viking Therapeutics, Inc. across metrics and forecast periods.
Estimates are grouped by forecast period, with low, average and high together. A dash means that statistic is not available.
Only independently verified consensus published through the company's investor-relations sources is available.
Consensus not yet available
Only independently verified consensus published through the company's investor-relations sources is available.
Key facts
CIK
1607678
CUSIP
92686J106
13F (30d)
211 filings
210 filers
Visit website
Investor relations